Derivative exercise or conversion — not an open-market buy.
Traded Feb 11, 2026 · Filed Feb 12, 2026
HCA Healthcare's SVP & Controller sold $2.02M of HCA Healthcare shares. Nobody planned it ahead of time.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$2,020,000
Shares × reported transaction price
15 days after results of Jan 27, 2026, 72 days before results of Apr 24, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $531.47 on Feb 11, 2026, at its 52-week high, after a 12% rise over the previous 30 trading days
52-week range $306.30 (Feb 28, 2025) to $531.47 (Feb 11, 2026), 100% of the way up, from 251 adjusted closes. 30 trading days earlier: $474.02 on Dec 29, 2025. Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | -1.5% | +1.1% | -2.6% |
| 30 days | -2.8% | -1.9% | -0.9% |
| 90 days | -19.9% | +9.7% | -29.6% |
| 180 days | -23.3% | +13.3% | -36.6% |
Past results only. Not a forecast.
Derivative exercise or conversion — not an open-market buy.
Routine share withholding; mechanical by default.
11K → 8,853 shares held−16% of their stake
HCA Healthcare's & Chief Legal & Admin Off. sold $904K of HCA Healthcare shares. Nobody planned it ahead of time.